Return to homepagePandemic Pact

Identification of transcription factors that promote pulmonary infection

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R21AI194139-01A1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2026
    2028
  • Known Financial Commitments (USD)

    $452,375
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    PRINCIPAL INVESTIGATOR Alice Prince
  • Research Location

    United States of America
  • Lead Research Institution

    COLUMBIA UNIVERSITY HEALTH SCIENCES
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Abstract Opportunistic pathogens such as Pseudomonas aeruginosa and Klebsiella pneumoniae enjoy remarkable metabolic flexibility that enables them to rapidly adapt to diverse environmental niches including the human lung. P. aeruginosa aspirated into the lung from contaminated water, for example, rapidly accommodates to a variety of potential carbon sources, from which it optimizes its metabolic activity to secure a nidus of infection. We postulate that a few global regulators, such as the transcription factor RpoN, respond to specific environmental signals. RpoN then either positively or negatively regulates cascades of gene expression to optimize the bacterial bioenergetic response and direct proliferation. By using Irg1-/- mice and rpoN mutants in both species, we will determine if host itaconate, or other metabolites are sensed by rpoN and how this directs the pathogenesis of pneumonia. We will establish how the ensuing up or down-regulation of RpoN activity enables the selection of bacterial variants such as those producing biofilm, that are optimized for persistent pulmonary infection. K.pneumoniae occupy a similar environmental niche as P. aeruginosa, with metabolic adaptation and the expression of extracellular polysaccharides under rpoN control that are linked to protracted and often fatal infection. For both pathogens, we will use fluorescent promoter-fusion reporter constructs, optimized for codon usage in each species to follow rpoN activity in both clinical isolates as well as laboratory strains. Our goal is to identify the signals and transcription factors that enable pulmonary opportunists to successfully establish infection.